Aristada (aripiprazole lauroxil) is a brand-name drug that’s prescribed for schizophrenia in adults. It’s available as an intramuscular injection in two separate forms. The cost of Avastin with and ...

-- Retail Pharmacies, Including 900 Albertsons Locations, Added to the Provider Locator to Provide Injections of ARISTADA and VIVITROL; Additional Programs In Place to Deliver Support and Financial ...

The most common adverse events reported in the ARISTADA treatment group were injection site pain (17.2%), increase in weight (9.1%) and akathisia (9.1%). The most common adverse events reported in the ...

On October 5, the U.S. Food and Drug Administration approved Aristada (aripiprazole lauroxil) extended release injection to treat adults with schizophrenia. Aristada is administered by a health care ...

Results from the study showed that the 1064 mg dose of ARISTADA achieved therapeutically relevant plasma concentrations of aripiprazole with a PK profile that supports dosing once every two months.

This potential new two-month offering would expand the range of ARISTADA dosing intervals to include a third option for patients with schizophrenia. ARISTADA was approved by the FDA in October 2015 as ...

(HealthDay)—Aristada (aripiprazole lauroxil) extended release injection has been approved by the U.S. Food and Drug Administration to treat the disabling brain disorder schizophrenia, the agency said ...

Following injection into the body, ARISTADA undergoes two conversion steps to yield aripiprazole. This is a significant milestone for Alkermes and ARISTADA represents an important new treatment option ...

̶ Results from Long-Term Safety Study and Data from Healthcare Resource Utilization Research Offer Insights into Treatment Experiences for People Living with Schizophrenia or Bipolar I Disorder ̶ ...

Pharmacists at these designated Albertsons Companies locations throughout the U.S. now are available to provide injections of ARISTADA and VIVITROL. These Albertsons sites extend Alkermes' existing ...